Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters.
Saved in:
| Title: | Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters. |
|---|---|
| Authors: | Sui Y; Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Kar S; Bioqual Inc., Rockville, MD, United States., Chawla B; Bioqual Inc., Rockville, MD, United States., Hoang T; Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Yu Y; Cancer Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Wallace SM; Experimental Pathology Laboratories, Inc., Sterling, VA, United States., Andersen H; Bioqual Inc., Rockville, MD, United States., Berzofsky JA; Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Feb 07; Vol. 16, pp. 1514845. Date of Electronic Publication: 2025 Feb 07 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1514845 |
